XML 80 R59.htm IDEA: XBRL DOCUMENT v3.21.1
Shareholders Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 10, 2021
Dec. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Mar. 27, 2019
Number of sale of shares     3,427,043   2,590,364 4,577,043  
Proceeds from sale of stock     $ 400,000   $ 430,000 $ 1,550,000  
Common stock subscribed     65,000        
Number of shares issued to common stock 30,000            
Stock-based compensation expense   $ 2,000,000 $ 417,462 $ 57,201 $ 4,624,708  
Number of shares of consulting services   2,000,000          
Number of stock options granted     67,502   224,000 333,506  
Stock options, outstanding   557,506 625,008   224,000 557,506
Exercise prices granted     $ 0.60   $ 0.34 $ 0.53  
Vested shares amount     $ 49,213        
Risk free interest rate     2.00%     2.00%  
Expected life     5 years     5 years  
Dividend yield     0.00%     0.00%  
Expected volatility     79.00%        
Intrinsic value of options outstanding   $ 307,000 $ 331,000   $ 0 $ 307,000  
IPO [Member]              
Number of stock options granted     5,834     30,834  
Vested shares amount     $ 3,500     $ 18,500  
Minimum [Member]              
Exercise prices granted     $ 0.17     $ 0.17  
Expected volatility           204.00%  
Maximum [Member]              
Exercise prices granted     $ 0.60     $ 0.60  
Expected volatility           228.00%  
Founders [Member]              
Number of stock options granted     280,000     280,000  
Sponsorship Agreements [Member]              
Number of shares issued to common stock     63,249        
Stock-based compensation expense     $ 163,249        
Number of shares of consulting services     100,000        
Number of stock options granted     345,008     277,506  
Executives [Member]              
Number of shares issued to common stock     205,000        
Stock-based compensation expense     $ 205,000